VC
Vivo Capital Portfolio holdings
AUM
$977M
1-Year Return
209.68%
This Quarter Return
+35.03%
1 Year Return
+209.68%
3 Year Return
+1,480.07%
5 Year Return
+2,591.98%
10 Year Return
–
AUM
$893M
AUM Growth
-$316M
(-26%)
Cap. Flow
-$199M
Cap. Flow
% of AUM
-22.33%
Top 10 Holdings %
Top 10 Hldgs %
73.65%
Holding
46
New
3
Increased
4
Reduced
4
Closed
6
Top Buys
| 1 |
Aclaris Therapeutics
ACRS
|
$22M |
| 2 |
Cidara Therapeutics
CDTX
|
$18M |
| 3 |
DRUG
Bright Minds Biosciences
DRUG
|
$9.06M |
| 4 |
Delcath Systems
DCTH
|
$8.57M |
| 5 |
Trevi Therapeutics
TRVI
|
$7.73M |
Top Sells
| 1 |
Harmony Biosciences
HRMY
|
$104M |
| 2 |
SVA
Sinovac Biotech, Ltd
SVA
|
$76.3M |
| 3 |
VRNA
Verona Pharma
VRNA
|
$58.8M |
| 4 |
Viridian Therapeutics
VRDN
|
$13.3M |
| 5 |
ALX Oncology
ALXO
|
$7.34M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Verastem
VSTM
$636M
| $7.95M | 0.89% |
1,538,461
| – | – |
|
27
Unicycive Therapeutics
UNCY
$76.7M
| $7.92M | 0.89% |
997,015
+550,000
| +123% | +$4.37M |
|
|
RGLS
28
DELISTED
Regulus Therapeutics
RGLS
| $7.9M | 0.89% |
5,000,000
| – | – |
|
|
SLN
29
Silence Therapeutics
SLN
$260M
| $7.61M | 0.85% |
1,105,454
| – | – |
|
|
CMPS
30
Compass Pathways
CMPS
$481M
| $6.08M | 0.68% |
1,608,000
| – | – |
|
31
IO Biotech
IOBT
$119M
| $5.68M | 0.64% |
6,173,439
| – | – |
|
32
Aligos Therapeutics
ALGS
$76.5M
| $5.65M | 0.63% |
141,879
| – | – |
|
33
Compass Therapeutics
CMPX
$597M
| $5.16M | 0.58% |
3,556,023
| – | – |
|
|
ALLK
34
DELISTED
Allakos
ALLK
| $3.58M | 0.4% |
2,956,110
| – | – |
|
35
Corbus Pharmaceuticals
CRBP
$120M
| $1.97M | 0.22% |
166,794
| – | – |
|
36
Bolt Biotherapeutics
BOLT
$9.9M
| $1.88M | 0.21% |
176,065
| – | – |
|
37
Tenax Therapeutics
TENX
$27.7M
| $1.29M | 0.14% |
208,333
| – | – |
|
|
DBVT
38
DBV Technologies
DBVT
$238M
| $98.9K | 0.01% |
32,020
-238,867
| -88% | -$738K |
|
39
Q32 Bio
QTTB
$21.3M
| $70.7K | 0.01% |
20,559
| – | – |
|
40
Precision BioSciences
DTIL
$58.9M
| $17.8K | ﹤0.01% |
4,675
| – | – |
|
41
Adverum Biotechnologies
ADVM
$71.3M
| – | – |
-833,333
| Closed | -$5.85M |
|
|
42
ALX Oncology
ALXO
$58.9M
| – | – |
-4,034,522
| Closed | -$7.34M |
|
43
Codexis
CDXS
$220M
| – | – |
-388,144
| Closed | -$1.2M |
|
44
enGene Holdings
ENGN
$266M
| – | – |
-678,705
| Closed | -$4.48M |
|
|
45
Harmony Biosciences
HRMY
$2.08B
| – | – |
-2,606,247
| Closed | -$104M |
|
|
SVA
46
DELISTED
Sinovac Biotech, Ltd
SVA
| – | – |
-11,800,000
| Closed | -$76.3M |
|